Through the acquisition of betapharm Arzneimittel GmbH, Dr. Reddy’s has a significant presence in Germany, one of the largest generics markets in the world. Dr. Reddy’s also has a direct presence in other important European markets including the UK, Spain, Italy and Romania, and in the process of increasing its market share in Poland, France and Portugal. Other European markets are being tapped through out-licensing and partnerships with local firms.
Leveraging the pipeline developed for the US, our product pipeline for Europe seeks to address the significant market currently composed largely of innovator sales. With a globally competitive manufacturing base in India and pan-European regulatory expertise, Dr. Reddy’s has all the right ingredients to become a significant player in the European markets even beyond Germany.
|
